Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Rubio-San-Simón A
  • André N
  • Cefalo MG
  • Aerts I
  • Castañeda A
  • Benezech S
  • Makin G
  • van Eijkelenburg N
  • Nysom K
  • Marshall L
  • Gambart M
  • Hladun R
  • Rossig C
  • Bergamaschi L
  • Fagioli F
  • Carpenter B
  • Ducassou S
  • Owens C
  • Øra I
  • De Wilde B
  • Guerra-García P
  • Strullu M
  • Rizzari C
  • Ek T
  • Hettmer S
  • Gerber NU
  • Rawlings C
  • Diezi M
  • Palmu S
  • Ruggiero A
  • Verdú J
  • de Rojas T
  • Vassal G
  • Geoerger B
  • Moreno L
  • Bautista F

Grupos

Abstract

Data regarding real-world impact on cancer clinical research during COVID-19 are scarce. We analysed the impact of the COVID-19 pandemic on the conduct of paediatric cancer phase I-II trials in Europe through the experience of the Innovative Therapies for Children with Cancer (ITCC).

Datos de la publicación

ISSN/ISSNe:
0959-8049, 1879-0852

EUROPEAN JOURNAL OF CANCER  ELSEVIER SCI LTD

Tipo:
Article
Páginas:
82-91
PubMed:
33129040
Factor de Impacto:
3,354 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 16

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19, Clinical trials, Drug development, Healthcare policy, Paediatric haematology and oncology

Campos de Estudio

Cita

Compartir